Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field, which is seen as a new growth point that can drive industrial structure optimization and economic transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper provides an overview of the global biomanufacturing industry, including its development status and trends [5]. - It compares the biomanufacturing sectors of China and the United States, highlighting competitive dynamics [5]. - Future development trends in biomanufacturing are discussed, indicating potential growth areas [5]. Group 2: Policy Landscape - The report outlines major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025 [5]. - It details foreign biomanufacturing industry policies and their implications for the sector [5]. - Domestic policies related to biomanufacturing are also analyzed, providing insights into regulatory frameworks [5]. Group 3: Industry Map and Applications - The white paper presents a comprehensive map of the Chinese biomanufacturing industry, identifying key players and their roles [5]. - It analyzes the biomanufacturing industry chain and key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5][6]. - Specific applications of biomanufacturing in various sectors are highlighted, showcasing its versatility and potential impact [5]. Group 4: Key Enterprises and Investment Landscape - The report identifies ten leading enterprises in the Chinese biomanufacturing industry, providing insights into their operations and market positions [6]. - It summarizes the strategic directions of 15 listed companies in synthetic biology, indicating their focus areas and growth strategies [6]. - The investment landscape for synthetic biology in China is examined, detailing funding trends and opportunities from 2024 to mid-2025 [6]. Group 5: Challenges and Recommendations - The white paper discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market-related issues [6]. - It offers targeted policy recommendations to address these challenges, aiming to support the sustainable development of the biomanufacturing sector [6].

Core Viewpoint - The article discusses the development of an "artificial ocean carbon cycling system" that combines electrocatalysis and biocatalysis to capture CO₂ from seawater and convert it into valuable chemical products, addressing both ocean acidification and carbon reduction goals [2][3][4]. Group 1: Research Overview - The research was conducted by a collaboration between the Shenzhen Institute of Advanced Technology and the University of Electronic Science and Technology, focusing on a novel strategy for carbon capture and conversion [2][5]. - The system captures CO₂ from natural seawater with an efficiency of over 70% and can operate continuously for over 500 hours [3][4]. - The captured CO₂ is converted into formic acid using a high-activity bismuth-based catalyst, which is then transformed into biodegradable plastic monomers [3][4]. Group 2: Technological Innovations - A new electrolytic device was designed to overcome challenges such as electrode passivation and salt deposition, enhancing the efficiency of carbon capture [3]. - The engineered bacteria developed can efficiently metabolize high concentrations of formic acid, producing key monomers for biodegradable plastics [3][4]. Group 3: Industrial Applications - The research demonstrated the feasibility of scaling up from laboratory to pilot levels, successfully producing biodegradable plastics like PBS and PLA [4]. - The project aims to create an integrated "green factory" along coastal areas, continuously capturing CO₂ and converting it into green plastic materials [4]. - The platform has the potential to expand into a variety of products, including organic acids and surfactants, serving multiple industries such as materials, chemicals, pharmaceuticals, and food [4].

Core Viewpoint - The article discusses the upcoming China Industrial Biotechnology Innovation Forum and Bio-Manufacturing Industry Conference, emphasizing its role in promoting high-quality development in synthetic biology and bio-manufacturing through collaboration among various sectors [3][4]. Conference Overview - The conference has been held annually since 2007, becoming a significant platform for communication, showcasing, and collaboration in the field of industrial biotechnology and bio-manufacturing [3]. - The theme for the 2025 conference is "Synthetic Biology Driving Bio-Manufacturing," scheduled for October 24-26, 2025, at the Tianjin Binhai Crowne Plaza Hotel [4]. Organizational Structure - The event is organized by several prominent institutions, including the Chinese Society of Biotechnology and the Tianjin Institute of Industrial Biotechnology [4]. Conference Agenda - The agenda includes a series of forums focusing on various topics such as AI in bio-manufacturing, industrial strain innovation, and green biosynthesis of chemicals, with notable speakers from leading universities and research institutions [5][8][11][13][18]. Registration Information - Registration fees are set at 2500 RMB for regular attendees and 1500 RMB for students, with the registration period starting from October 1, 2025 [24][25]. Accommodation Guide - Several hotels near the conference venue offer discounted rates for attendees, with prices ranging from 299 RMB to 800 RMB per night, including breakfast [28][29][30].

Core Viewpoint - The article highlights the significance of the China Industrial Biotechnology Innovation Forum and Bio-Manufacturing Industry Conference as a vital platform for collaboration and innovation in the field of industrial biotechnology and bio-manufacturing, aiming to enhance the integration of various sectors including production, academia, research, finance, and talent [5][6]. Event Overview - The conference has been successfully held for twelve sessions since its inception in 2007, establishing itself as a prominent event in China's industrial biotechnology and bio-manufacturing sectors [5]. - The forum aims to foster deep integration of innovation chains, industry chains, capital chains, and talent chains to promote high-quality development in synthetic biology and bio-manufacturing [5]. Key Activities - The event will feature the release of the "China Industrial Biotechnology Development White Paper 2025," which attendees can receive in printed form [6][10]. - The conference will include various sub-forums focusing on topics such as AI in bio-manufacturing, autonomous innovation in industrial strains, and green biosynthesis of chemicals [14][15]. Registration Information - Registration fees are structured with different rates for regular and student representatives, with early registration offering lower fees [15]. - The conference will provide meals and materials for registered attendees, while accommodation and travel expenses are to be covered by the participants [15]. Contact Information - The article provides contact details for inquiries related to the conference, including multiple contacts for assistance [19][20][21].

Core Viewpoint - Zhejiang University Quzhou Research Institute and BASF have established a strategic innovation partnership to promote the development of sustainable materials and processes [2] Group 1: Strategic Collaboration - The collaboration will focus on advanced materials, industrial ecology, molecular manufacturing, and bio-based chemicals [2] - Key technologies, cutting-edge technologies, and related standards will be co-developed and innovated [2] - The strategic cooperation framework agreement was signed by Lou Jianfeng (Chairman and President of BASF Greater China) and Ren Qilong (Academician of the Chinese Academy of Engineering and Director of Zhejiang University Quzhou Research Institute) [2] Group 2: Research Institute Overview - Zhejiang University Quzhou Research Institute was established on December 28, 2018, as a collaborative innovation institution between Zhejiang University and Quzhou City [5] - The institute focuses on technological innovation and achievement transformation in key areas such as new materials and new energy [5] - It aims to create a high-end chemical concept verification center and a shared pilot platform, building a comprehensive innovation system that spans technology tackling, concept verification, pilot maturation, fund empowerment, and industrial application [5] Group 3: Industry Developments - A synthetic biological manufacturing new materials project with an annual output of 50,000 tons has commenced in Hunan, utilizing reeds and straw as raw materials to produce biodegradable polymers [8] - An investment of 50 million has been announced for a synthetic biological enterprise's production line project for bio-based products [8] - Maidefa Bio has secured medical-grade bio-based PHA microsphere registration, leading the innovation in biomedical materials [8] - Two departments have launched initiatives to capture the bio-based materials market, focusing on non-grain bio-based material industry case studies [8]

Core Viewpoint - Yuan Tian Biotechnology has successfully completed a pre-A++ round financing of several tens of millions, which will be used for the construction of a 5,000-ton production line and the planning of a 100,000-ton production line, aiming to accelerate the large-scale production of bio-enzyme regenerated materials [2]. Group 1: Financing and Investment - Yuan Tian Biotechnology has completed three rounds of financing within a year, with investments from various notable institutions, indicating the unique value and development potential of its technology [3]. - The latest financing round was exclusively led by Tian Chuang Capital, which aims to support the company's capacity expansion and new product development in the green materials sector [5]. Group 2: Technological Advancements - The company has developed the PET degrading enzyme YTZYME™, which enhances the degradation efficiency of waste PET from "300 years in nature" to "8 hours in industrial conditions," addressing challenges in recycling blended fabrics [5]. - Yuan Tian Biotechnology is expanding its recycling technology matrix from PET to PA6, providing innovative solutions for the sustainable use of PA6 materials in various industries [6][8]. Group 3: Market Potential and Strategy - The market for recycled bio-based PET (rbPET) is significant and essential, with Yuan Tian's bio-enzyme method offering broad raw material adaptability, high recovery rates, and cost advantages, positioning the company as a potential leader in the global green circular materials field [5]. - Following the recent financing, the company plans to accelerate the construction of its production lines and enhance market promotion efforts to expand the application of bio-enzyme regenerated materials across more industries [8].

Core Viewpoint - The article discusses the initiative by the Ministry of Industry and Information Technology and the Ministry of Agriculture and Rural Affairs of China to promote the innovation and development of non-grain bio-based materials, focusing on key technology innovation, application scenario expansion, and the cultivation of characteristic bases [1][4]. Group 1: Recommended Directions - The initiative emphasizes three main directions: key technology innovation, application scenario expansion, and characteristic base cultivation [2][4]. - Key technology innovation focuses on disruptive and leading technologies in areas such as industrial strains and enzyme protein components, non-grain biomass saccharification, and efficient purification of low-concentration products [2][5]. - Application scenario expansion targets the commercialization of bio-based materials in various products like household plastics, engineering plastics, and medical materials, validated in sectors such as logistics, hospitality, and agriculture [2][5]. - Characteristic base cultivation aims to develop industrial bases that effectively address the challenges of collecting and transporting non-grain biomass, contributing positively to regional economic development [2][5]. Group 2: Application Conditions - Eligible applicants include registered production enterprises, research institutions, and industrial parks in China, which must demonstrate sound management and compliance with safety and environmental standards [6]. - The cases submitted should possess high technical standards and complete solutions, with key technologies having independent intellectual property rights and being domestically leading [6]. - Application materials must be objective and truthful, providing real application cases and supporting documents [6]. Group 3: Recommendation Process - The recommendation process involves organizing applications at the provincial level, verifying and recommending cases, and ultimately promoting a selection of significant cases nationwide [6][7]. - Provincial departments will conduct a review of submitted cases and compile a recommendation summary to be sent to the Ministry of Industry and Information Technology [6][7]. - The Ministry will then promote these cases through various media channels and industry events to facilitate knowledge sharing and commercial cooperation [7]. Group 4: Support and Promotion - The initiative includes measures to enhance publicity for recommended cases through mainstream media and industry platforms, fostering experience exchange and collaboration [7]. - Policy support will be provided for the transformation and application of industrial results, including financial backing for relevant enterprises and projects [7]. - Local governments are encouraged to offer additional support for outstanding cases with replicable value, aiding in technology research and product promotion [7].

Project Overview - The project involves the establishment of a thousand-ton bio-based product production line, focusing on 1,3-PDO, calcium lactate, vanillin, and sialic acid processing [3] - The total investment for the project is 50 million yuan, with 5 million yuan allocated for environmental protection [3] - The production capacity upon completion will be 720 tons of 1,3-PDO, 940 tons of calcium lactate, 30 tons of vanillin, and 10 tons of sialic acid annually [3] Company Background - Si Peng Bio-materials (Nantong) Co., Ltd. is a wholly-owned subsidiary of Shanghai Si Peng Technology Co., Ltd., established in May 2022 [4] - The company focuses on negative carbon synthetic biology and is led by a team of scientists from Shanghai Jiao Tong University [4] - It has developed a unique one-step method for synthesizing polylactic acid (PLA) from carbon dioxide, achieving a 70% reduction in carbon emissions [4] - The company has partnered with Angel Yeast to establish a thousand-ton production line, with products including bio-based polyols and biodegradable plastics [4] Industry Insights - The bio-based materials sector is witnessing significant developments, with various companies making strides in bio-manufacturing technologies [8] - The market for bio-based materials is projected to grow substantially, indicating a competitive landscape for companies involved in this field [8]

Core Viewpoint - The article highlights the upcoming Synbio China 2025 event, focusing on the integration of scientists, entrepreneurs, and investors in the field of synthetic biology, emphasizing its strategic importance for the development of China's bio-economy [33]. Event Details - The Synbio China 2025 event will take place on August 1-2, 2025, at the Suzhou International Expo Center, alongside the 7th CMC-China Expo [1]. - Confirmed attendees include experts from various universities such as Beijing University of Chemical Technology, Shanghai Jiao Tong University, and East China University of Science and Technology, as well as representatives from companies like Micro Factory and Henan Biological Industry Group [2]. Agenda Highlights - The agenda includes lectures from academicians and experts, covering topics such as the opportunities and challenges in the industrialization of synthetic biology, and innovative pathways for non-grain biomass potential [6][7]. - Specific sessions will focus on enabling technologies, including enzyme engineering and CRISPR/Cas9 applications, as well as the development of bio-based materials and their industrial applications [8][10]. Industry Challenges - The article discusses the rapid dissemination of synthetic biology concepts in China, while also addressing challenges such as achieving scalable production, realizing the value of synthetic biological products, and fostering innovation in core competitiveness [33]. Networking Opportunities - The event aims to facilitate face-to-face interactions among founders, industry experts, investors, and government representatives, providing a platform for project promotion and industry guidance [35]. Participation and Registration - Attendees are encouraged to register for free through a QR code provided in the article, ensuring access to the event and its networking opportunities [4][12]. Additional Information - The 7th CMC-China Expo is expected to attract around 20,000 participants, featuring 450 exhibiting companies and 600 invited guests, with multiple forums dedicated to cutting-edge topics in the industry [79].

Core Viewpoint - Synthetic biology and biomanufacturing are gaining significant attention and support from various sectors, including government, academia, and industry, highlighting their potential as new productive forces in the economy [1][17]. Event Overview - The SynBio China Third China Synthetic Biology "Scientists + Entrepreneurs + Investors" Expo will be held on August 1-2, 2025, at the Suzhou International Expo Center, featuring over 20,000 participants [3][33]. - The expo will include seven sub-conferences focusing on various aspects of synthetic biology, including health, food, and beauty industries [3]. Industry Challenges - Despite rapid dissemination of synthetic biology concepts in China, the industry faces challenges such as achieving scalable production, realizing product value, market exploration, and innovation in core competitiveness [17]. Applications and Innovations - Synthetic biology is driving innovations in functional ingredients, next-generation food additives, and personalized health foods, showcasing its transformative potential in the food industry [11][12]. - The technology is also advancing in the beauty sector, with applications in functional skincare ingredients and medical aesthetics [15][18]. Collaboration and Networking - The event aims to facilitate collaboration among innovators, industry experts, and investors, providing a platform for project promotion and industry guidance [20].